Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

Journal of Virology

Volumn 74, Issue 19, 2000, Pages 9028-9038

  Nousbaum, J B ^a   Polyak, S J ^a   Ray, S C ^a   Sullivan, D G ^a   Larson, A M ^a   Carithers R L , Jr ^a   Gretch, D R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERFERON INDUCTION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS RESISTANCE;

AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; MUTATION; RIBAVIRIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033807806     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.19.9028-9038.2000     Document Type: Article

References (59)

1. Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity
2. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
3. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
4. Genetic organization and diversity of the hepatitis C virus
5. Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus
6. Analysis of a successful immune response against hepatitis C virus
7. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region
8. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N.
9. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
10. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A gene
11. Mutations in the nonstructural protein 5A and response to interferon in patients with chronic hepatitis C virus 1b infection
12. PHYLIP - Phylogeny inference package
13. Confidence limits on phylogenesis: An approach using the bootstrap
14. Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: Relation to viral genotype, cryoglobulinemia and response to interferon
15. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein
16. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
17. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
18. Study of the genetic heterogeneity of the NS5A region of the HCV-1b genome and evolution under interferon alfa therapy
19. Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-alpha
20. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C
21. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
22. RNA virus populations as quasispecies
23. Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit
24. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A
25. New methods for estimating the numbers of synonymous and nonsynonymous substitutions
26. Genomic structure of the human prototype strain H of hepatitis C virus: Comparison with American and Japanese isolates
27. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome
28. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator
29. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis
30. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients
31. Specificity of the hepatitis C virus NS3 serine protease: Effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing
32. Identification of a highly conserved sequence element at the Y terminus of hepatitis C virus genome RNA
33. Analysis of genotypes and amino acid residues 2209-2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy
34. High dose induction interferon therapy improves early response rate in naive genotype 1 patients
35. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution
36. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
37. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
38. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group
39. The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease
40. Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response
41. Interferon resistance of hepatitis C virus genotype 1b: Relationship to nonstructural 5A gene quasispecies mutations
42. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C
43. Characterization of the effects of hepatitis C virus non-structural 5A protein expression in human cell lines and on interferon-sensitive virus replication
44. Antiviral resistance in hepatitis C: Further evidence for ISDR-independent NS5A-mediated interferon resistance in vitro
45. Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection
46. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
47. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy
48. Identification of the major phosphorylation site of the hepatitis C vires H strain NS5A protein as serine 2321
49. Phosphorylation of the Hepatitis C virus NS5A protein in vitro and in vivo: Properties of the NS5A-associated kinase
50. Cell mediated immune response to the hepatitis C virus
51. The prognostic relevance of the non-structural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus
52. Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response
53. Characteristics of nucleotide substitution in the hepatitis C virus genome: Constraints on sequence change in coding regions at both ends of the genome
54. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa
55. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling
56. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast
57. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A
58. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa